Brinker Capital Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-38,449
| Closed | -$4.38M | – | 1686 |
|
2022
Q4 | $4.38M | Buy |
38,449
+901
| +2% | +$103K | 0.09% | 229 |
|
2022
Q3 | $2.32M | Buy |
37,548
+721
| +2% | +$44.6K | 0.05% | 396 |
|
2022
Q2 | $2.94M | Sell |
36,827
-269
| -0.7% | -$21.5K | 0.06% | 330 |
|
2022
Q1 | $3.9M | Buy |
37,096
+4,357
| +13% | +$458K | 0.06% | 302 |
|
2021
Q4 | $3.53M | Sell |
32,739
-3,058
| -9% | -$330K | 0.05% | 367 |
|
2021
Q3 | $3.35M | Hold |
35,797
| – | – | 0.05% | 376 |
|
2021
Q2 | $3.35M | Buy |
35,797
+29,692
| +486% | +$2.78M | 0.04% | 430 |
|
2021
Q1 | $562K | Sell |
6,105
-33,113
| -84% | -$3.05M | 0.01% | 870 |
|
2020
Q4 | $2.87M | Buy |
39,218
+34,437
| +720% | +$2.52M | 0.04% | 464 |
|
2020
Q3 | $371K | Buy |
+4,781
| New | +$371K | 0.01% | 970 |
|
2020
Q1 | – | Sell |
-483
| Closed | -$17K | – | 832 |
|
2019
Q4 | $17K | Hold |
483
| – | – | ﹤0.01% | 524 |
|
2019
Q3 | $13K | Hold |
483
| – | – | ﹤0.01% | 550 |
|
2019
Q2 | $12K | Buy |
+483
| New | +$12K | ﹤0.01% | 764 |
|
2017
Q4 | – | Sell |
-227
| Closed | -$3K | – | 636 |
|
2017
Q3 | $3K | Hold |
227
| – | – | ﹤0.01% | 544 |
|
2017
Q2 | $3K | Hold |
227
| – | – | ﹤0.01% | 456 |
|
2017
Q1 | $3K | Hold |
227
| – | – | ﹤0.01% | 440 |
|
2016
Q4 | $4K | Buy |
227
+224
| +7,467% | +$3.95K | ﹤0.01% | 450 |
|
2016
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 657 |
|
2016
Q1 | – | Sell |
-5
| Closed | – | – | 744 |
|
2015
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 779 |
|